The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients
Top Cited Papers
- 1 October 2004
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 40 (15), 2293-2306
- https://doi.org/10.1016/j.ejca.2004.06.019
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trialThe Lancet, 2003
- Guidelines for the use of epoetin in cancer patients: a much-needed step forward in standardizing anemia treatmentBlood, 2003
- Pretreatment haemoglobin levels significantly predict the tumour response to primary chemotherapy in human breast cancerBritish Journal of Cancer, 2003
- Breast cancer trial with erythropoietin terminated unexpectedlyThe Lancet Oncology, 2003
- Multivariate regression analyses of data from a randomised, double-blind, placebo-controlled study confirm quality of life benefit of epoetin alfa in patients receiving non-platinum chemotherapyBritish Journal of Cancer, 2002
- Use of Epoetin in Patients With Cancer: Evidence-Based Clinical Practice Guidelines of the American Society of Clinical Oncology and the American Society of HematologyJournal of Clinical Oncology, 2002
- Changing patient perceptions of the side effects of cancer chemotherapyCancer, 2002
- Randomized, Double-Blind, Placebo-Controlled Trial of Recombinant Human Erythropoietin, Epoetin Beta, in Hematologic MalignanciesJournal of Clinical Oncology, 2002
- Symptomatology of anemiaSeminars in Oncology, 2001
- Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramideJournal of Chronic Diseases, 1960